CHICAGO (AP) — CHICAGO (AP) — Xeris Biopharma Holdings, Inc. (XERS) on Thursday reported a loss of $19 million in its first quarter.

On a per-share basis, the Chicago-based company said it had a loss of 14 cents.

The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 12 cents per share.

The company posted revenue of $40.6 million in the period, which also missed Street forecasts. Five analysts surveyed by Zacks expected $41.6 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on XERS at https://www.zacks.com/ap/XERS